TR199600316A1 - Antiaritmik ve kardioprotektiv ikame edilmis indenoilguanidler. - Google Patents

Antiaritmik ve kardioprotektiv ikame edilmis indenoilguanidler.

Info

Publication number
TR199600316A1
TR199600316A1 TR96/00316A TR9600316A TR199600316A1 TR 199600316 A1 TR199600316 A1 TR 199600316A1 TR 96/00316 A TR96/00316 A TR 96/00316A TR 9600316 A TR9600316 A TR 9600316A TR 199600316 A1 TR199600316 A1 TR 199600316A1
Authority
TR
Turkey
Prior art keywords
indenoilguanides
antiarrhythmic
cardioprotective
substituted
useful
Prior art date
Application number
TR96/00316A
Other languages
English (en)
Inventor
Nirogi Venkata Sat Ramakrishna
Tulsidas Sitaram More
Anagra Suhas Kulkarni
Bansi Lal
Roa Venkata Satya Ve Vadlamudi
Anil Vasantrao Ghate
Ravindra Dattatraya Gupte
Dr Wolfgang Scholz
Dr Hans-Jochen Lang
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of TR199600316A1 publication Critical patent/TR199600316A1/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
TR96/00316A 1995-04-18 1996-04-16 Antiaritmik ve kardioprotektiv ikame edilmis indenoilguanidler. TR199600316A1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95105724 1995-04-18
US08/633,223 US5733934A (en) 1995-04-18 1996-04-16 Antiarrythmic and cardioprotective substituted indenoylguanidines

Publications (1)

Publication Number Publication Date
TR199600316A1 true TR199600316A1 (tr) 1997-03-21

Family

ID=26138562

Family Applications (1)

Application Number Title Priority Date Filing Date
TR96/00316A TR199600316A1 (tr) 1995-04-18 1996-04-16 Antiaritmik ve kardioprotektiv ikame edilmis indenoilguanidler.

Country Status (23)

Country Link
US (1) US5733934A (tr)
EP (1) EP0738712B1 (tr)
JP (1) JPH08291131A (tr)
CN (1) CN1061648C (tr)
AT (1) ATE183498T1 (tr)
AU (1) AU706055B2 (tr)
BR (1) BR9601989A (tr)
CA (1) CA2174406A1 (tr)
CZ (1) CZ291538B6 (tr)
DE (1) DE69603771T2 (tr)
DK (1) DK0738712T3 (tr)
ES (1) ES2135811T3 (tr)
GR (1) GR3031540T3 (tr)
HU (1) HUP9600998A3 (tr)
IL (1) IL117927A (tr)
NO (1) NO305655B1 (tr)
NZ (1) NZ286380A (tr)
PL (1) PL182566B1 (tr)
RU (1) RU2182902C2 (tr)
SI (1) SI0738712T1 (tr)
SK (1) SK282011B6 (tr)
TR (1) TR199600316A1 (tr)
ZA (1) ZA963046B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055475A1 (en) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
TW462964B (en) * 1998-05-26 2001-11-11 Sumitomo Pharma Guanidine derivatives for the treatment and prevention of disorders caused by inhibiting hyperactivity of Na/H exchange transport system and process for producing the same
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
EP1180029A4 (en) 1999-04-23 2002-10-02 Bristol Myers Squibb Co BICYCLIC ACYL IHIBITORING SODIUM / PROTON EXCHANGER AND RELATED PROCEDURE.
WO2004112687A2 (en) * 2003-06-26 2004-12-29 Biotron Limited Antiviral acylguanidine compounds and methods
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4326005A1 (de) * 1993-08-03 1995-02-09 Hoechst Ag Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
DE69603771D1 (de) 1999-09-23
DK0738712T3 (da) 2000-03-06
BR9601989A (pt) 1998-04-07
NZ286380A (en) 1997-09-22
CA2174406A1 (en) 1996-10-19
HUP9600998A3 (en) 1997-11-28
IL117927A (en) 2001-12-23
US5733934A (en) 1998-03-31
EP0738712A1 (en) 1996-10-23
CN1061648C (zh) 2001-02-07
SK282011B6 (sk) 2001-10-08
PL182566B1 (pl) 2002-01-31
JPH08291131A (ja) 1996-11-05
NO961521L (no) 1996-10-21
RU2182902C2 (ru) 2002-05-27
HU9600998D0 (en) 1996-06-28
CZ291538B6 (cs) 2003-03-12
ES2135811T3 (es) 1999-11-01
DE69603771T2 (de) 2000-09-07
SK48396A3 (en) 1996-12-04
NO961521D0 (no) 1996-04-17
AU5067696A (en) 1996-10-31
AU706055B2 (en) 1999-06-10
SI0738712T1 (en) 1999-12-31
HUP9600998A2 (en) 1997-01-28
NO305655B1 (no) 1999-07-05
CN1140164A (zh) 1997-01-15
IL117927A0 (en) 1996-08-04
ATE183498T1 (de) 1999-09-15
CZ109696A3 (en) 1996-11-13
EP0738712B1 (en) 1999-08-18
ZA963046B (en) 1996-10-22
MX9601424A (es) 1997-07-31
GR3031540T3 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
DE68920125T2 (de) Pyrimidindion-Derivate, Verfahren zu deren Herstellung und diese enthaltende antiarrythmische Mittel.
DK0379979T3 (tr)
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
TR199600316A1 (tr) Antiaritmik ve kardioprotektiv ikame edilmis indenoilguanidler.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
IL97855A0 (en) Bromide containing pharmaceutical compositions for treatment of psoriasis
ATE86993T1 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
HK1067948A1 (en) Antitumor indolopyprolocarbazole derivative
DE69206321D1 (de) Ursane Derivate, ihre Herstellung und die enthaltende pharmazeutische Zusammensetzung.
AR004481A1 (es) Indenoilguanidinas sustituidas antiarritmicas y cardioprotectoras
ES2066147T3 (es) Derivados de la 1,4-dihidro-4-oxo-3-quinolina como agentes antibacterianos en mamiferos selectivamente toxicos.
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE109454T1 (de) Catecholaminester.
RU92016472A (ru) Противовирусные средства, содержащие гетерополимолибдаты, способ лечения или профилактики инфекций, связанных с ретровирусом, применение гетерополимолибдатов для получения лекарственных средств, гетерополимолибдаты
TH17758EX (th) สารเคมี
TH13535EX (th) "สารประกอบใหม่"
MX9606397A (es) Cromanilsulfonil(tio)ureas sustituidas, procedimientos para prepararlas, y su utilizacion en preparados farmaceuticos, asi como preparados farmaceuticos que las contienen.